162 related articles for article (PubMed ID: 34173362)
1. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
[TBL] [Abstract][Full Text] [Related]
4. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
5. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
6. Concurrent primary vitreoretinal and spinal cord lymphoma: a unique entity.
Ezon IC; Barteselli G; Rosenberg J; Freeman WR
JAMA Ophthalmol; 2014 Jul; 132(7):902-4. PubMed ID: 25010176
[No Abstract] [Full Text] [Related]
7. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
[TBL] [Abstract][Full Text] [Related]
8. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
[TBL] [Abstract][Full Text] [Related]
9. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
[TBL] [Abstract][Full Text] [Related]
11. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
12. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M;
Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095
[TBL] [Abstract][Full Text] [Related]
13. Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series.
Cimino L; Coassin M; Chan CC; Marchi S; Belpoliti M; Fanti A; Iovieno A; Fontana L
Indian J Ophthalmol; 2016 May; 64(5):369-75. PubMed ID: 27380976
[TBL] [Abstract][Full Text] [Related]
14. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of secondary vitreoretinal lymphoma after diagnostic vitrectomy: case report.
Gan L; Ye J
BMC Ophthalmol; 2023 May; 23(1):222. PubMed ID: 37198561
[TBL] [Abstract][Full Text] [Related]
17. ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA.
Lavine JA; Singh AD; Sharma S; Baynes K; Lowder CY; Srivastava SK
Retina; 2019 Oct; 39(10):1861-1871. PubMed ID: 30044267
[TBL] [Abstract][Full Text] [Related]
18. Primary Vitreoretinal Lymphoma in HIV Infection.
Steffen J; Coupland SE; Smith JR
Ocul Immunol Inflamm; 2021 Apr; 29(3):621-627. PubMed ID: 32453669
[No Abstract] [Full Text] [Related]
19. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.
Deák GG; Goldstein DA; Zhou M; Fawzi AA; Jampol LM
JAMA Ophthalmol; 2019 Feb; 137(2):194-198. PubMed ID: 30489610
[TBL] [Abstract][Full Text] [Related]
20. Serial Detection of
Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
